Amanote Research
Register
Sign In
Anti-Cd47 Agent Boosts Macrophage Activity in NHL
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-nb2018-155
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
November 21, 2018
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
TMIC-04. A POTENT MICROGLIAL RESPONSE TO BLOCKING THE CD47-SIRPα ANTI-PHAGOCYTIC AXIS OVERCOMES DEFICIENT MACROPHAGE RECRUITMENT DURING ANTI-CD47 IMMUNOTHERAPY AGAINST GLIOBLASTOMA
Neuro-Oncology
Cancer Research
Oncology
Neurology
Anticancer Effects of Anti-Cd47 Immunotherapy in Vivo
OncoImmunology
Oncology
Allergy
Immunology
The Novel Bispecific Cd47-Cd19 Antibody Tg-1801 Potentiates the Activity of Ublituximab-Umbralisib (U2) Drug Combination in Preclinical Models of B-NHL
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Overall Estimation of Anti-Oxidant Activity by Mammal Macrophage
Open Journal of Rheumatology and Autoimmune Diseases
Anti-Inflammatory Activity of Yanshu Spraying Agent in Animal Models
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
979 Caffeine Boosts Skin’s Mitochondrial Activity
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Echinacea Increases Arginase Activity and Has Anti-Inflammatory Properties in RAW 264.7 Macrophage Cells, Indicative of Alternative Macrophage Activation
Journal of Ethnopharmacology
Drug Discovery
Pharmacology
Pre-Clinical Pharmacology of AZD3965, a Selective Inhibitor of McT1: DLBCL, NHL and Burkitt’s Lymphoma Anti-Tumor Activity
Oncotarget
Oncology
Cathepsins Drive Anti-Inflammatory Activity by Regulating Autophagy and Mitochondrial Dynamics in Macrophage Foam Cells
Cellular Physiology and Biochemistry
Physiology
